These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 3313041)

  • 1. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
    N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemfibrozil, lipids, and coronary risk.
    Rifkind BM
    N Engl J Med; 1987 Nov; 317(20):1279-81. PubMed ID: 3313042
    [No Abstract]   [Full Text] [Related]  

  • 3. The Gemfibrozil Study.
    Manninen V
    Acta Med Scand Suppl; 1985; 701():83-8. PubMed ID: 3907298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
    Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Helsinki Heart Study: basic design and randomization procedure.
    Mänttäri M; Elo O; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    Eur Heart J; 1987 Oct; 8 Suppl I():1-29. PubMed ID: 3322826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
    Adabag AS; Mithani S; Al Aloul B; Collins D; Bertog S; Bloomfield HE;
    Am Heart J; 2009 May; 157(5):913-8. PubMed ID: 19376321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gemfibrozil on serum lipids.
    Samuel P
    Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil therapy in patients with coronary heart disease.
    Bell H; Dittmeier G; Martinez L
    Mo Med; 1988 Jan; 85(1):27-30. PubMed ID: 3277032
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.
    Stefanick ML; Mackey S; Sheehan M; Ellsworth N; Haskell WL; Wood PD
    N Engl J Med; 1998 Jul; 339(1):12-20. PubMed ID: 9647874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
    Rubins HB; Robins SJ; Collins D; Fye CL; Anderson JW; Elam MB; Faas FH; Linares E; Schaefer EJ; Schectman G; Wilt TJ; Wittes J
    N Engl J Med; 1999 Aug; 341(6):410-8. PubMed ID: 10438259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Koskinen P; Kovanen PT; Tuomilehto J; Manninen V
    Arch Intern Med; 1992 Jan; 152(1):90-6. PubMed ID: 1728934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I.
    Crepaldi G; Baggio G; Arca M; Avellone G; Avogaro P; Bittolo Bon G; Bompiani GD; Capurso A; Cattin L; D'Alŏ G
    Arch Intern Med; 1991 Jan; 151(1):146-52. PubMed ID: 1898694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helsinki Heart Study. New perspectives in the prevention of coronary heart disease.
    Huttunen JK; Frick MH; Heinonen OP; Heinsalmi P; Manninen V; Mänttäri M; Romo M
    Drugs; 1988; 36 Suppl 3():32-6. PubMed ID: 3076118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.